Casey Mark J 4
4 · NOVAVAX INC · Filed Mar 5, 2025
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Casey Mark J
EVP, Chief Legal Officer
Transactions
- Award
2025 Non-statutory Stock Option NQ
2025-03-03$7.87/sh+169,000$1,330,030→ 169,000 totalExercise: $7.87Exp: 2035-03-03→ Common Stock (169,000 underlying) - Award
2025 Restricted Stock Units RSU
2025-03-03+112,500→ 112,500 totalExercise: $0.00Exp: 2035-03-03→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- [F2]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.